ArticleMolecular cancer therapeutics2014

Effector-mediated eradication of precursor B acute lymphoblastic leukemia with a novel Fc-engineered monoclonal antibody targeting the BAFF-R.

Reshmi Parameswaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.